Open Access Open Access  Restricted Access Subscription or Fee Access

The effects of QuikClot Combat Gauze and Celox Rapid on hemorrhage control

Don Johnson, PhD, Michelle Johnson, DNP, CRNA

Abstract


Objective: Compare QuikClot Combat Gauze (QCG) and Celox Rapid (CR) for initial hemostasis and over a 1-hour period.

Design: Experimental study.

Setting: Approved animal laboratory.

Subjects: Twenty-one Yorkshire swine.

Interventions: Subjects were randomly assigned to either the QCG (n = 11) or CR (n = 10) group. An arteriotomy was made in the right femoral artery with a 6-mm vascular punch. Bleeding was allowed for 45 seconds. QCG or CR was applied followed by firm pressure for 3 minutes according to Committee on Tactical Combat Casualty Care guidelines. A 10-pound weight simulating a pressure dressing was applied, and the wound was observed for 1 hour. Dressing failure was bleeding > 2 percent of blood volume.

Main outcome measures: Achievement and maintenance of hemostasis and amount of hemorrhage during observation. Odds of successful hemostasis.

Results: QCG was significantly better than CR in initial hemostasis (p = 0.049) and maintaining hemostasis over 1 hour (p = 0.020). One hundred percent of QCG subjects and 70 percent of CR subjects achieved initial hemostasis. During the 1-hour observation, one additional CR subject failed to maintain hemostasis. CR had significantly more hemorrhage than QCG during the 1-hour observation (p = 0.027). QCG had no bleeding compared to CR that had a mean of 162 ± 48 mL (standard error of mean) over 2 minutes. QCG had 15.9 times greater odds of success compared to CR over a period of 1 hour. Over the 1-hour observation time, 100 percent of QCG achieved hemostasis compared to 60 percent of CR.

Conclusions: QCG is more effective than CR.


Keywords


QuikClot Combat Gauze, Celox Rapid, hemorrhage control, bleeding

Full Text:

PDF

References


Hendrickson RG, Horowitz BZ: Disaster preparedness. In Tintinalli JE, Stapczynski JS, Ma OJ, et al. (eds.): Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 9th ed. New York, NY: McGraw-Hill Education, 2018.

Johnson D, Westbrook DM, Phelps D, et al.: The effects of QuikClot Combat Gauze on hemorrhage control when used in a porcine model of lethal femoral injury. Am J Disaster Med. 2014; 9(4): 309-315.

Crawford N: Human Cost of Post 9/11 Wars: Lethality and Transparency. Providence, RI: Watson Institute of International and Public Affairs, Brown University, 2018.

Dowling MB, Chaturvedi A, MacIntire IC, et al.: Determination of efficacy of a novel alginate dressing in a lethal arterial injury model in swine. Injury. 2016; 47(10): 2105-2109.

McCaughey BG, Garrick J, Carey LC, et al.: Naval Support Activity Hospital Da Nang combat casualty deaths January to June 1968. Mil Med. 1987; 152(6): 284-289.

Kelly JF, Ritenour AE, McLaughlin DF, et al.: Injury severity and causes of death from Operation Iraqi Freedom and Operation Enduring Freedom: 2003-2004 versus 2006. J Trauma. 2008; 64(2 suppl): S21-S26; discussion S26-S27.

Carey ME: Analysis of wounds incurred by U.S. Army Seventh Corps personnel treated in Corps hospitals during Operation Desert Storm, February 20 to March 10, 1991. J Trauma. 1996; 40(3 suppl): S165-S169.

Eastridge BJ Mabry RL Seguin P, et al.: Death on the battlefield (2001-2011): Implications for the future of combat casualty care. J Trauma Acute Care Surg. 2012; 73(6)(suppl 5): S431-S437.

Lozano R, Naghavi M, Foreman K, et al.: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2095-2128.

Schauer SG, April MD, Naylor JF, et al.: Prehospital application of hemostatic agents in Iraq and Afghanistan. Prehosp Emerg Care. 2018; 22(5): 614-623.

Schauer SG, Naylor JF, April MD, et al.: Prehospital resuscitation performed on hypotensive trauma patients in Afghanistan: The prehospital trauma registry experience. Mil Med. 2019; 184: e154-e157.

Kauvar DS, Dubick MA, Walters TJ, et al.: Systematic review of prehospital tourniquet use in civilian limb trauma. J Trauma Acute Care Surg. 2018; 84(5): 819-825.

Kauvar DS, Miller D, Walters TJ: Tourniquet use is not associated with limb loss following military lower extremity arterial trauma. J Trauma Acute Care Surg. 2018; 85(3): 495-499.

Johnson D, Bates S, Nukalo S, et al.: The effects of QuikClot Combat Gauze on hemorrhage control in the presence of hemodilution and hypothermia. Ann Med Surg (Lond). 2014; 3(2): 21-25.

Cosgriff N, Moore EE, Sauaia A, et al.: Predicting life-threatening coagulopathy in the massively transfused trauma patient: Hypothermia and acidoses revisited. J Trauma. 1997; 42(5): 857-861; discussion 861-852.

Heckbert SR, Vedder NB, Hoffman W, et al.: Outcome after hemorrhagic shock in trauma patients. J Trauma. 1998; 45(3): 545-549.

Sauaia A, Moore FA, Moore EE, et al.: Early predictors of postinjury multiple organ failure. Arch Surg. 1994; 129(1): 39-45.

Horst HM, Dlugos S, Fath JJ, et al.: Coagulopathy and intraoperative blood salvage (IBS). J Trauma. 1992; 32(5): 646-652; discussion 652-643.

Champion HR, Bellamy RF, Roberts CP, et al.: A profile of combat injury. J Trauma. 2003; 54(5 suppl): S13-S19.

Gegel B, Burgert J, Gasko J, et al.: The effects of QuikClot Combat Gauze and movement on hemorrhage control in a porcine model. Mil Med. 2012; 177(12): 1543-1547.

Johnson D Agee S Reed A, et al.: The effects of QuikClot Combat Gauze on hemorrhage control in the presence of hemodilution. US Army Med Dep J. 2012: 36-39.

MedTrade Products Ltd.: Celox. Crewe, UK: MedTrade Products Ltd. Available at http://www.celoxmedical.com23. Accessed March 3, 2019.

QuikClot: Available at https://quikclot.com/QuikClot/About-QuikClot. Accessed March 3, 2019.

Garcia-Blanco J, Gegel B, Burgert J, et al.: The effects of movement on hemorrhage when QuikClot(R) Combat Gauze is used in a hypothermic hemodiluted porcine model. J Spec Oper Med. 2015; 15(1): 57-60.

Kheirabadi BS, Scherer MR, Estep JS, et al.: Determination of efficacy of new hemostatic dressings in a model of extremity arterial hemorrhage in swine. J Trauma. 2009; 67(3): 450-459; discussion 459-460.

Ran Y, Hadad E, Daher S, et al.: QuikClot Combat Gauze use for hemorrhage control in military trauma: January 2009 Israel Defense Force experience in the Gaza Strip—A preliminary report of 14 cases. Prehosp Disaster Med. 2010; 25(6): 584-588.

Travers S, Dubourg O, Ribeiro Parenti L, et al.: [Prehospital use of haemostatic dressing QuikClot ACS + for hemorrhage control of a perineal trauma]. Ann Fr Anesth Reanim. 2012; 31(12): 969-971.

Zietlow JM, Zietlow SP, Morris DS, et al.: Prehospital use of hemostatic bandages and tourniquets: Translation from military experience to implementation in civilian trauma care. J Spec Oper Med. 2015; 15(2): 48-53.

Vilardo N, Feinberg J, Black J, et al.: The use of QuikClot combat gauze in cervical and vaginal hemorrhage. Gynecol Oncol Rep. 2017; 21: 114-116.

Roberts JS, Niu J, Pastor-Cervantes JA: Comparison of hemostasis times with a kaolin-based hemostatic pad (QuikClot Radial) vs mechanical compression (TR Band) following transradial access: A pilot prospective study. J Invasive Cardiol. 2017; 29(10): 328-334.

Devlin JJ, Kircher S, Kozen BG, et al.: Comparison of ChitoFlex(R), CELOX, and QuikClot(R) in control of hemorrhage. J Emerg Med. 2011; 41(3): 237-245.

Rhee P, Brown C, Martin M, et al.: QuikClot use in trauma for hemorrhage control: Case series of 103 documented uses. J Trauma. 2008; 64(4): 1093-1099.

Mahajna A, Hirsh M, Krausz MM: Use of the hemostatic agent QuikClot for the treatment of massive splenic injury in a rat model. Eur Surg Res. 2007; 39(4): 251-257.

Schauer SG, April MD, Naylor JF, et al.: QuikClot(R) Combat Gauze(R) use by ground forces in Afghanistan: The Prehospital Trauma Registry experience. J Spec Oper Med. 2017; 17(2): 101-106.

Gegel BT, Austin PN, Johnson AD: An evidence-based review of the use of a combat gauze (QuikClot) for hemorrhage control. AANA J. 2013; 81(6): 453-458.

Kunio NR, Riha GM, Watson KM, et al.: Chitosan based advanced hemostatic dressing is associated with decreased blood loss in a swine uncontrolled hemorrhage model. Am J Surg. 2013; 205(5): 505-510.

Kheirabadi BS, Arnaud F, McCarron R, et al.: Development of a standard swine hemorrhage model for efficacy assessment of topical hemostatic agents. J Trauma. 2011; 71(1 suppl): S139-S146.

Clark JD, Gebhart GF, Gonder JC, et al.: Special report: The 1996 guide for the care and use of laboratory animals. ILAR J. 1997; 38(1): 41-48.

Tactical Combat Casualty Care Guidelines. August 1, 2018. Available at https://www.naemt.org/docs/default-source/educationdocuments/tccc/tccc-mp/guidelines/tccc-guidelines-for-medical-personnel-180801.pdf?sfvrsn=13fc892_2. Accessed March 3, 2019.

Pusateri AE, Holcomb JB, Kheirabadi BS, et al.: Making sense of the preclinical literature on advanced hemostatic products. J Trauma. 2006; 60(3): 674-682.

Pusateri AE, McCarthy SJ, Gregory KW, et al.: Effect of a chitosan- based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine. J Trauma. 2003; 54(1): 177-182.

Chung F, Abdullah HR, Liao P: STOP-Bang questionnaire: A practical approach to screen for obstructive sleep apnea. Chest. 2016; 149(3): 631-638.

De Castro GP, Dowling MB, Kilbourne M, et al.: Determination of efficacy of novel modified chitosan sponge dressing in a lethal arterial injury model in swine. J Trauma Acute Care Surg. 2012; 72(4): 899-907.




DOI: http://dx.doi.org/10.5055/ajdm.2019.0312

Refbacks

  • There are currently no refbacks.
This site uses cookies to maintain session information critical to the user's experience and environment on this system. Click "Accept Cookies" to continue.
For more details please visit our privacy statement at: Privacy & GDPR